skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Platelet and vascular smooth muscle thromboxane A/sup 2//prostaglandin H/sub 2/ receptors

Conference · · Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States)
OSTI ID:6846825

Thromboxane A/sub 2/ (TxA/sub 7/) and prostaglandin H/sub 2/ (PGH/sub 2/) aggregate platelets and contract vascular smooth muscle. Inasmuch as both compounds produce the same effects and presumably through the same receptor, their receptors have been referred to as TxA/sub 2//PGH/sub 2/ receptors. Pharmacological studies of stable agonists and antagonists of the TxA/sub 2//PGH/sub 2/ receptors have shown different rank order potencies for these compounds in platelets compared with blood vessels. These studies have provided evidence to support the hypothesis that the platelet TxA/sub 2//PGH/sub 2/ receptor is different from the one found in vascular tissue. The vascular receptor has been named (TxA/sub 2//PGH/sub 2/)/sub ..cap alpha../. In the past few years several radiolabeled antagonists and agonists have been developed and used in radioligand-binding studies, primarily in platelets. One of these ligands, /sup 125/I-labeled PTA-OH, a TxA/sub 2//PGH/sub 2/ receptor antagonist, has been extensively used to characterize the human platelet TxA/sub 2//PGH/sub 2/-binding site. It has been found to have a K/sub d/ of approximately 20 nM and a B/sub max/ of 2500 binding sites/platelet. Through the combination of pharmacological and biochemical approaches, it should be possible to characterize platelet and vascular TxA/sub 2//PGH/sub 2/ receptors.

Research Organization:
Medical Univ. of South Carolina, Charleston
OSTI ID:
6846825
Journal Information:
Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States), Vol. 46:1; Conference: 70. annual meeting of the Federation of American Societies for Experimental Biology, St. Louis, MO, USA, 15 Apr 1986
Country of Publication:
United States
Language:
English